# From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy

> **NCT04673604** · NA · COMPLETED · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 42 (actual)

## Conditions studied

- Glaucoma
- Ocular Surface Disease

## Interventions

- **DIAGNOSTIC_TEST:** Assessment of ocular surface staining (Oxford score 0-15 scale)
- **DRUG:** mean diurnal intraocular pressure-lowering

## Key facts

- **NCT ID:** NCT04673604
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-06
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-06-29
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04673604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04673604, "From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04673604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*